References
- Bonte FJ, Curry GC, Parkey RW. Experimental studies of the splanchnic circulation of the rabbit after ligation of the superior mesenteric artery. I. Angiographic and physiologic studies. Am J Roentgenol Radium Ther Nucl Med 1969; 106: 691-699 https://doi.org/10.2214/ajr.106.4.691
- Burgener FA, Violante MR. Comparison of hepatic VX2-carcinomas after intra-arterial, intraportal and intraparenchymal tumor cell injection. An angiographic and computed tomographic study in the rabbit. Invest Radiol 1979; 14: 410-414 https://doi.org/10.1097/00004424-197909000-00005
- Chen MC, Tsang YM, Stark DD, Weissleder R, Saini S, Brandhorst J, White DL, Engelstad BL, Ferrucci JT. Hepatic metastases: rat models for imaging research. Magn Reson Imaging 1989; 7: 1-8 https://doi.org/10.1016/0730-725X(89)90318-4
- Choi BI, Lee DH, Han MC. Necrotic areas in VX2 carcinoma of rabbits. Correlation of magnetic resonance imaging and pathologic appearance. Invest Radiol 1993; 28:33-38 https://doi.org/10.1097/00004424-199301000-00010
- Izumi B, Tashiro S, Miyauchi Y. Anticancer effects of local administration of mitomycin C via the hepatic artery or portal vein on implantation and growth of VX2 cancer injected into rabbit liver. Cancer Res 1986; 46: 4167-4170
- Kidd JG, Rous P. A transplantable rabbit carcinoma originating in a virus-induced papilloma and containing the virus in masked or altered form. J Exp Med 1940; 71: 813-837 https://doi.org/10.1084/jem.71.6.813
- Lin WY, Chen J, Lin Y, Han K. Implantation of VX2 carcinoma into the liver of rabbits: a comparison of three direct-injection methods. J Vet Med Sci 2002; 64: 649-652 https://doi.org/10.1292/jvms.64.649
- Nakakuma K, Tashiro S, Hiraoka T, Ogata K, Ootsuka K. Hepatocellular carcinoma and metastatic cancer detected by iodized oil. Radiology 1985; 154: 15-17 https://doi.org/10.1148/radiology.154.1.2981111
- Nishizaki T, Matsumata T, Kanematsu T, Yasunaga C, Sugimachi K. Surgical manipulation of VX2 carcinoma in the rabbit liver evokes enhancement of metastasis. J Surg Res 1990; 49: 92-97 https://doi.org/10.1016/0022-4804(90)90116-J
- Rougier P, Munck JN, Elias D, Herait P, Bognel C, Gosse C, Lasser P. Intra-arterial hepatic chemotherapy with pirarubicin. Preclinical and clinical studies. Am J Clin Oncol 1990; 13: 1-4 https://doi.org/10.1097/00000421-199012001-00001
- Shope RE, Hurst EW. Infectious papillomatosis of rabbits; with a note on the histopathology. J Exp Med 1933; 58: 607-624 https://doi.org/10.1084/jem.58.5.607
- Tabuchi Y, Nakamura T, Saitoh Y. Liver metastases induced by implantation of VX2 cancer into the gastrointestine. J Surg Res 1991; 50: 216-222 https://doi.org/10.1016/0022-4804(91)90181-K
- Tamura Y, Sakata Y, Tsushima K, Narushima S, Yamada Y, Ogasawara H, Ito T, Saitoh S, Suzuki H, Yoshida Y. A novel model of solitary hepatic tumor in rats using ascites hepatoma AH13: suitability for chemotherapeutic studies. Jpn J Cancer Res 1990; 81: 1045-1051 https://doi.org/10.1111/j.1349-7006.1990.tb03344.x
- Thorstensen O, Isberg B, Svahn U, Jorulf H, Venizelos N, Jaremko G. Experimental tissue transplantation using a biopsy instrument and radiologic methods. Invest Radiol 1994; 29: 469-471 https://doi.org/10.1097/00004424-199404000-00015
- Violante MR, Dean PB. Improved detectability of VX2 carcinoma in the rabbit liver with contrast enhancement in computed tomography. Radiology 1980; 134: 237-239 https://doi.org/10.1148/radiology.134.1.7350611
- Wolf W, Presant CA, Servis KL, el-Tahtawy A, Albright MJ, Barker PB, Ring R 3rd' Atkinson D, Ong R, King M, Singh M, Ray M, Wiseman C, Blayney D, Shani J. Tumor trapping of 5-fluorouracil: in vivo 19F NMR spectroscopic pharmacokinetics in tumor-bearing humans and rabbits. Proc Natl Acad Sci USA 1990; 87: 492-496 https://doi.org/10.1073/pnas.87.1.492
- Yang R, Rescorla FJ, Reilly CR, Faught PR, Sanghvi NT, Lumeng L, Franklin TD Jr, Grosfeld JL. A reproducible rat liver cancer model for experimental therapy: introducing a technique of intrahepatic tumor implantation. J Surg Res 1992; 52: 193-198 https://doi.org/10.1016/0022-4804(92)90072-8